HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bouzat, C. Articles by Barrantes, F. J. Search for Related Content PubMed PubMed Citation Articles by Bouzat, C. Articles by Barrantes, F. J. Social Bookmarking                      What's this?

Volume 271, Number 42, Issue of October 18, 1996 pp. 25835-25841
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Modulation of Muscle Nicotinic Acetylcholine Receptors by the Glucocorticoid Hydrocortisone
POSSIBLE ALLOSTERIC MECHANISM OF CHANNEL BLOCKADE

(Received for publication, June 27, 1996, and in revised form, August 5, 1996)

From the Instituto de Investigaciones Bioquímicas, 8000 Bahía Blanca, Argentina

Mechanisms of ion channel blockade by noncompetitive inhibitors of the nicotinic acetylcholine receptor (AChR) have been particularly difficult to elucidate. We have combined here transient expression of embryonic, adult, and a mutated adult muscle AChR associated with a slow channel syndrome (Ohno, K., Hutchinson, D. O., Milone, M., Brengman, J. M., Bouzat, C., Sine, S., and Engel, A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 758-762) with single channel recordings to determine subunit specificity and mechanisms of action of the prototype glucocorticoid hydrocortisone (HC). HC affected in a similar manner the gating kinetics of all types of muscle AChR, producing briefer openings with normal amplitudes. We postulate that this steroid acts as a noncompetitive inhibitor of the AChR and that its mechanism of action can be interpreted in terms of blocking models. The forward rate constant for the blocking process was also similar for all channel types, indicating that the structural differences between them are not responsible for the effect. The reduction in the channel open time was not dependent on agonist concentration; it was slightly voltage dependent, suggesting that HC binds to a site located inside the membrane that senses the electric field. Recordings at high acetylcholine concentration in the presence of HC showed a reduced number of openings per activation period and the long closed times typically observed in the desensitization phenomenon. In competition studies with the classical open channel blocker QX-222, HC induced an early termination of the burst, suggesting that the two act at different sites. Taken together the results support the existence of specific sites sensed by the membrane field, different from those of open channel blockers and probably located at the lipid-protein interface. From this site(s), glucocorticoids and other hydrophobic noncompetitive inhibitors could allosterically mediate channel blockade.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. E. Wiltfong and M. Jansen Probing Protein Packing Surrounding the Residues in and Flanking the Nicotinic Acetylcholine Receptor M2M3 Loop J. Neurosci., February 11, 2009; 29(6): 1626 - 1635. [Abstract] [Full Text] [PDF]

				G. A. F. Nievas, F. J. Barrantes, and S. S. Antollini Modulation of Nicotinic Acetylcholine Receptor Conformational State by Free Fatty Acids and Steroids J. Biol. Chem., August 1, 2008; 283(31): 21478 - 21486. [Abstract] [Full Text] [PDF]

				K. Paradiso, K. Sabey, A. S. Evers, C. F. Zorumski, D. F. Covey, and J. H. Steinbach Steroid Inhibition of Rat Neuronal Nicotinic alpha 4beta 2 Receptors Expressed in HEK 293 Cells Mol. Pharmacol., August 1, 2000; 58(2): 341 - 351. [Abstract] [Full Text]

				M. P. Blanton, Y. Xie, L. J. Dangott, and Jonathan. B. Cohen The Steroid Promegestone Is a Noncompetitive Antagonist of the Torpedo Nicotinic Acetylcholine Receptor that Interacts with the Lipid-Protein Interface Mol. Pharmacol., February 1, 1999; 55(2): 269 - 278. [Abstract] [Full Text]

				C. Bouzat, A. M. Roccamo, I. Garbus, and F. J. Barrantes Mutations at Lipid-Exposed Residues of the Acetylcholine Receptor Affect Its Gating Kinetics Mol. Pharmacol., July 1, 1998; 54(1): 146 - 153. [Abstract]